Treatment of Carpal tunnel syndrome symptoms with Nucleo CMP Forte

• Conditions: Carpal Tunnel Syndrome (CTS); MedDRA version: 17.0Level: LLTClassification code 10052414Term: Unilateral carpal tunnel syndromeSystem Organ Class: 100000004852; Therapeutic area: Diseases [C] - Nervous System Diseases [C10]

• Registration Number: EUCTR2014-003272-23-ES
• Lead Sponsor: Dr. Jordi Montero Homs- Unidad de Neuromuscular- Servicio de Neurología- Hospital Universitario de Bellvitge

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2014-09-09
• Last Update Posted: 3 November 2014

Recruitment & Eligibility

• Status: Authorised-recruitment may be ongoing or finished
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

1) Patients between 18 and 80 years old.

2) Patients clinically and electrophysiological diagnosed with CTS, who won?t require a premature surgical procedure.

3) Patients able to understand the study objective and able to give the Inform Consent.
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 40
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 10

Exclusion Criteria

1) Pregnant or breastfeeding woman.

2) Patients with high probablility os not completing the study requirements according to the investigator criteria.

3) Patients with dysphagia which won?t allow them to take the study medication.

4) Patients diagnosed with neuropathy which is causing an axonal degeneration.

5) Patients with a recent forearm trauma.

6) Patients participating in antother Clinical Trial.

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified